Position in GILD
as of Jun 30, 2026
· filed Jul 31, 2026
Position Value
$1,532,251
-$143,115 QoQ
Shares Held
12,128
+0.9% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.86%
of 13F equity value
Holder Rank
#920
of 2,266 holders
Holding Since
Jun 2020
23 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Probity Advisors, Inc. holds $17,628,696 across 10 Drug Manufacturers - General names. GILD ranks #5 (8.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
2,714 | $3,255,253 | |
| 2 | ABBV |
AbbVie Inc.
|
12,209 | $3,072,272 | |
| 3 | MRK |
Merck & Co., Inc.
|
19,934 | $2,561,519 | |
| 4 | JNJ |
Johnson & Johnson
|
9,274 | $2,355,317 | |
| 5 | GILD |
Gilead Sciences, Inc.
This page
|
12,128 | $1,532,251 | |
| 6 | GSK |
GSK plc
|
24,377 | $1,277,842 | |
| 7 | PFE |
Pfizer Inc
|
50,988 | $1,227,791 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
20,006 | $1,152,745 |
All Filings in GILD
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,532,251 | 12,128 | Shares | Sole | 2026-07-31 | |
| 2026-03-31 | $1,675,366 | 12,021 | Shares | Sole | 2026-04-28 | |
| 2025-12-31 | $1,526,885 | 12,440 | Shares | Sole | 2026-01-27 | |
| 2025-09-30 | $1,453,323 | 13,093 | Shares | Sole | 2025-10-30 | |
| 2025-06-30 | $1,498,518 | 13,516 | Shares | Sole | 2025-07-30 | |
| 2025-03-31 | $1,558,167 | 13,906 | Shares | Sole | 2025-05-09 | |
| 2024-12-31 | $1,334,838 | 14,451 | Shares | Sole | 2025-03-05 | |
| 2024-09-30 | $1,274,535 | 15,202 | Shares | Sole | 2024-10-16 | |
| 2024-06-30 | $940,368 | 13,706 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $841,203 | 11,484 | Shares | Sole | 2024-05-03 | |
| 2023-12-31 | $944,171 | 11,655 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $769,483 | 10,268 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $731,625 | 9,493 | Shares | Sole | 2023-08-10 | |
| 2022-12-31 | $774,882 | 9,026 | Shares | Sole | 2023-02-15 | |
| 2022-09-30 | $570,509 | 9,248 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $656,422 | 10,620 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $620,479 | 10,437 | Shares | Sole | 2022-05-10 | |
| 2021-12-31 | $769,157 | 10,593 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $704,507 | 10,086 | Shares | Sole | 2021-10-08 | |
| 2021-06-30 | $646,595 | 9,390 | Shares | Sole | 2021-08-06 | |
| 2021-03-31 | $511,417 | 7,913 | Shares | Sole | 2021-04-28 | |
| 2020-09-30 | $309,251 | 4,894 | Shares | Sole | 2020-11-09 | |
| 2020-06-30 | $301,758 | 3,922 | Shares | Sole | 2020-08-03 | |
| No filing history on record for this holder in this stock. | ||||||